科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/08/21 | 3,900 | 3,900 | 3,866 | 3,866 | -38 | -1% | 108,900 |
| 2025/08/20 | 3,907 | 3,928 | 3,889 | 3,904 | -28 | -0.7% | 128,600 |
| 2025/08/19 | 3,929 | 3,942 | 3,883 | 3,932 | +70 | +1.8% | 123,300 |
| 2025/08/18 | 3,859 | 3,898 | 3,855 | 3,862 | +2 | +0.1% | 117,500 |
| 2025/08/15 | 3,871 | 3,877 | 3,853 | 3,860 | -5 | -0.1% | 102,500 |
| 2025/08/14 | 3,890 | 3,924 | 3,856 | 3,865 | -35 | -0.9% | 133,600 |
| 2025/08/13 | 3,865 | 3,900 | 3,860 | 3,900 | +33 | +0.9% | 84,100 |
| 2025/08/12 | 3,891 | 3,923 | 3,864 | 3,867 | -14 | -0.4% | 181,600 |
| 2025/08/08 | 3,940 | 3,940 | 3,808 | 3,881 | -95 | -2.4% | 221,600 |
| 2025/08/07 | 4,010 | 4,010 | 3,952 | 3,976 | -43 | -1.1% | 125,300 |
| 2025/08/06 | 4,002 | 4,056 | 3,998 | 4,019 | +17 | +0.4% | 130,000 |
| 2025/08/05 | 3,990 | 4,030 | 3,985 | 4,002 | +12 | +0.3% | 75,800 |
| 2025/08/04 | 3,955 | 3,991 | 3,949 | 3,990 | +6 | +0.2% | 90,400 |
| 2025/08/01 | 3,977 | 4,013 | 3,974 | 3,984 | +28 | +0.7% | 115,500 |
| 2025/07/31 | 3,975 | 3,975 | 3,953 | 3,956 | +1 | ±0% | 92,800 |
| 2025/07/30 | 3,930 | 3,972 | 3,930 | 3,955 | -5 | -0.1% | 80,800 |
| 2025/07/29 | 3,929 | 3,967 | 3,929 | 3,960 | +22 | +0.6% | 80,800 |
| 2025/07/28 | 3,967 | 3,977 | 3,938 | 3,938 | -17 | -0.4% | 74,300 |
| 2025/07/25 | 3,940 | 3,958 | 3,901 | 3,955 | +22 | +0.6% | 105,900 |
| 2025/07/24 | 3,932 | 3,949 | 3,903 | 3,933 | +38 | +1% | 122,200 |
| 2025/07/23 | 3,858 | 3,909 | 3,839 | 3,895 | +71 | +1.9% | 146,300 |
| 2025/07/22 | 3,853 | 3,864 | 3,809 | 3,824 | -26 | -0.7% | 117,300 |
| 2025/07/18 | 3,850 | 3,863 | 3,841 | 3,850 | +1 | ±0% | 75,600 |
| 2025/07/17 | 3,801 | 3,855 | 3,801 | 3,849 | +28 | +0.7% | 84,300 |
| 2025/07/16 | 3,805 | 3,834 | 3,779 | 3,821 | +21 | +0.6% | 101,000 |
| 2025/07/15 | 3,778 | 3,815 | 3,768 | 3,800 | +11 | +0.3% | 75,900 |
| 2025/07/14 | 3,770 | 3,789 | 3,761 | 3,789 | +14 | +0.4% | 105,000 |
| 2025/07/11 | 3,757 | 3,804 | 3,757 | 3,775 | +7 | +0.2% | 110,300 |
| 2025/07/10 | 3,780 | 3,787 | 3,745 | 3,768 | -12 | -0.3% | 115,600 |
| 2025/07/09 | 3,759 | 3,792 | 3,712 | 3,780 | +40 | +1.1% | 171,400 |
| 2025/07/08 | 3,767 | 3,780 | 3,739 | 3,740 | -28 | -0.7% | 99,400 |
| 2025/07/07 | 3,790 | 3,807 | 3,768 | 3,768 | -22 | -0.6% | 83,500 |
| 2025/07/04 | 3,813 | 3,815 | 3,783 | 3,790 | -6 | -0.2% | 83,200 |
| 2025/07/03 | 3,768 | 3,808 | 3,751 | 3,796 | +32 | +0.9% | 98,100 |
| 2025/07/02 | 3,792 | 3,802 | 3,764 | 3,764 | -27 | -0.7% | 125,100 |
| 2025/07/01 | 3,802 | 3,823 | 3,772 | 3,791 | -29 | -0.8% | 156,000 |
| 2025/06/30 | 3,830 | 3,855 | 3,817 | 3,820 | -6 | -0.2% | 118,700 |
| 2025/06/27 | 3,800 | 3,826 | 3,788 | 3,826 | +25 | +0.7% | 247,800 |
| 2025/06/26 | 3,810 | 3,846 | 3,787 | 3,801 | -9 | -0.2% | 157,300 |
| 2025/06/25 | 3,829 | 3,829 | 3,771 | 3,810 | -29 | -0.8% | 153,700 |
| 2025/06/24 | 3,845 | 3,857 | 3,811 | 3,839 | +22 | +0.6% | 140,800 |
| 2025/06/23 | 3,817 | 3,836 | 3,800 | 3,817 | -27 | -0.7% | 116,500 |
| 2025/06/20 | 3,825 | 3,857 | 3,794 | 3,844 | +19 | +0.5% | 343,600 |
| 2025/06/19 | 3,860 | 3,873 | 3,822 | 3,825 | -35 | -0.9% | 150,900 |
| 2025/06/18 | 3,845 | 3,877 | 3,845 | 3,860 | -10 | -0.3% | 106,500 |
| 2025/06/17 | 3,838 | 3,958 | 3,831 | 3,870 | +3 | +0.1% | 209,200 |
| 2025/06/16 | 3,880 | 3,892 | 3,845 | 3,867 | +12 | +0.3% | 80,600 |
| 2025/06/13 | 3,876 | 3,897 | 3,839 | 3,855 | -18 | -0.5% | 115,900 |
| 2025/06/12 | 3,842 | 3,873 | 3,834 | 3,873 | +31 | +0.8% | 173,500 |
| 2025/06/11 | 3,859 | 3,883 | 3,828 | 3,842 | -3 | -0.1% | 90,700 |
1～
50
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 386,600円 | -6.4% | -71.8% | 4.91% | 43.06倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| サンバイオ | 250,600円 | - | - | 0.00% | - | 116.07倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 東和薬品 | 297,400円 | +7.9% | -3.3% | 2.69% | 8.27倍 | 0.85倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ジーエヌアイ | 267,800円 | +21.7% | +999.9% | 0.00% | 12.33倍 | 4.22倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
